$200K — $250K *
TScan Therapeutics is a startup biotech seeking to revolutionize life-changing therapeutics for patients by identifying novel T cells and epitopes. We are looking for an experienced Director of Project Management to take ownership, control, and responsibility of the one or more projects to ensure key deliverables and timelines are fit for purpose, remain on schedule and to budget, whilst maintaining quality across functions. The ideal candidate should have a scientific background, experience in drug development, driving projects from Discovery to Development and an IND/CTA. Details regarding responsibilities are listed below.
T-Scan Therapeutics was founded in 2018 by a small group of scientists led by Dr. Stephen Elledge (Harvard Medical School/HHMI). TScan is discovering and developing novel TCR-engineered T cell therapies for the treatment of cancer. TScan’s discovery platform is centered around a breakthrough technology that enables the rapid, comprehensive, and genome-wide identification of the peptide antigen targets of T cell receptors. This technology greatly enhances our ability to understand the specific antigens that drive important disease processes, including tumor cell recognition by the immune system, self-reactivity in autoimmune disorders, and acquired immunity in infectious disease. TScan is using the platform in oncology to discover new TCR/target pairs and to rapidly move novel TCRs into clinical development.
Valid through: 12/5/2021
$100K — $150K *
26 days ago